At issue is an attempt by the administration to encourage greater use of lower-cost, but equally effective, medicines covered by the Part B program, which pays for injectable and infused drugs for the elderly. The move reflects growing concern over the rising cost of medications, a hot-button topic that is straining public and private payer budgets, and angering Americans.
Read Full Article »
